Attached files

file filename
EX-10.1 - EXHIBIT 10.1 - Medefile International, Inc.ex101.htm
UNITED STATES
 
SECURITIES AND EXCHANGE COMMISSION
 
Washington, D.C. 20549

FORM 8-K
 
CURRENT REPORT
 
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 

Date of Report (Date of earliest event reported):  January 20, 2013
 
MedeFile International, Inc.
(Exact Name of Registrant as Specified in Charter)
 
Nevada
033-25126 D
85-0368333
(State or other jurisdiction
of incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)
 
 
301 Yamato Road
Suite 1200
Boca Raton, FL
33431
(Address of principal executive offices)
(Zip Code)

Registrant’s telephone number, including area code: (561) 912-3393
 
 
(Former name or former address, if changed since last report)
 
Copies to:
Richard A. Friedman, Esq.
Jeff Cahlon, Esq.
Sichenzia Ross Friedman Ference LLP
61 Broadway, 32nd Floor
New York, New York 10006
Telephone: (212) 930-9700

 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
  o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
  o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
  o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
  o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 
 

 
 
Item 1.01 Entry into a Material Definitive Agreement

On January 20, 2013, MedeFile International, Inc. (the “Company”) entered into and closed a securities purchase agreement with an accredited investor (the “Investor”) pursuant to which the Company sold 400,000 shares of common stock for a purchase price of $200,000.

In connection with the foregoing, the Company relied on the exemption from registration provided by Section 4(2) of the Securities Act of 1933, as amended, for transactions not involving a public offering.

Item 3.02 Unregistered Sales of Equity Securities.

See Item 1.01.

Item 9.01 Financial Statements and Exhibits
 
 (d)           Exhibits.
 
Exhibit No.
 
Description
10.1
 
Securities Purchase Agreement, dated January 20, 2013, between the Company and the Investor

 

 
 

 

SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
 
MEDEFILE INTERNATIONAL, INC.
 
       
Date:  February 5, 2013
By:
/s/  Kevin Hauser
 
   
Name:  Kevin Hauser
 
   
Title: Chief Executive Officer